1. Role of tyrosine kinase inhibitors in cancer therapy;Arora;J. Pharmacol. Exp. Ther.,2005
2. The potential of panHER inhibition in cancer;Wang;Front. Oncol.,2015
3. A comprehensive review of clinical trials on egfr inhibitors such as cetuximab andpanitumumab as monotherapy and in combination for treatment of metastaticcolorectal cancer, Avicenna;Yazdi;J. Med. Biotechnol.,2015
4. Phase I study of everolimus, cetuximab and irinotecan as second-line therapy in metastatic colorectal cancer;Hecht;Anticancer Res.,2015
5. A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor malignancies;Deeken;Cancer,2015